Valuation Photocure ASA

Stocks

Real-time Oslo Bors 02:45:08 22/09/2026 pm IST			5-day change	1st Jan Change
52.10 ^NOK	-1.33%		+1.96%	-27.03%

16/08	Photocure Sees Potential in US FDA's Proposed Reclassification of Cystoscopy Systems	MT
15/08	Photocure ASA Initiates FDA Proposal To Reclassify Blue Light Cystoscopy Systems From Class III To Class II	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,769	2,895	1,827	1,681	1,900	1,421	-	-
Change	-	4.55%	-36.89%	-8.01%	13.04%	-25.19%	-	-
Enterprise Value (EV) ¹	2,483	2,639	1,567	1,387	1,661	1,252	1,264	1,262
Change	-	6.28%	-40.61%	-11.53%	19.77%	-24.6%	0.96%	-0.21%
P/E	-89.3x	-40.2x	6,740x	-344x	-1,190x	18.7x	67.7x	45.5x
PBR	-	-	-	-	-	3.95x	3.63x	3.41x
PEG	-	-0x	-67x	0x	17.9x	-0x	-0.9x	0.9x
Capitalization / Revenue	7.68x	7.73x	4.09x	3.42x	3.57x	2.16x	2.13x	1.97x
EV / Revenue	6.89x	7.05x	3.51x	2.82x	3.12x	1.9x	1.9x	1.75x
EV / EBITDA	136x	-107x	28.2x	28.2x	57.8x	11.9x	17.3x	14.6x
EV / EBIT	-426x	-53.9x	56.4x	68x	-2,229x	11.3x	29.9x	23.1x
EV / FCF	113x	-469x	35.4x	18.4x	95x	19x	112x	51.8x
FCF Yield	0.89%	-0.21%	2.82%	5.43%	1.05%	5.27%	0.9%	1.93%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-1.15	-2.66	0.01	-0.18	-0.06	2.83	0.78	1.16
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	360.5	374.5	446.2	491.7	532.6	658.3	666.3	720.3
EBITDA ¹	18.3	-24.63	55.49	49.19	28.73	105.7	73	86.67
EBIT ¹	-5.826	-49	27.81	20.4	-0.745	110.3	42.33	54.67
Net income ¹	-30.9	-71.86	0.267	-4.81	-1.519	76.33	21	31.67
Net Debt ¹	-285.4	-255.6	-259.5	-293.9	-238.9	-169	-157	-159.7
Reference price ²	102.70	106.80	67.40	62.00	71.40	52.80	52.80	52.80
Nbr of stocks (in thousands)	26,960	27,106	27,106	27,106	26,607	26,917	-	-
Announcement Date	23/02/22	23/02/23	21/02/24	19/02/25	18/02/26	-	-	-

¹NOK in Million²NOK

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
PHOTOCURE ASA	18.66x	1.9x	11.85x	-	15Cr
ELI LILLY AND COMPANY	33.12x	12.04x	24.4x	0.6%	1,03800Cr
JOHNSON & JOHNSON	29.97x	6.67x	18.66x	1.99%	65TCr
ABBVIE INC.	33.44x	7.83x	16.17x	2.59%	47TCr
ROCHE HOLDING AG	19.76x	4.83x	11.96x	2.74%	36TCr
NOVARTIS AG	19.95x	5.21x	12.92x	3.08%	27TCr
ASTRAZENECA PLC	21.41x	4.44x	12.62x	1.99%	26TCr
AMGEN INC.	24.9x	6.52x	11.62x	2.57%	21TCr
NOVO NORDISK A/S	11.64x	4.24x	8.76x	4.32%	18TCr
GILEAD SCIENCES, INC.	-45.54x	6.63x	25.88x	2.19%	19TCr
Average	16.73x	6.03x	15.49x	2.45%	36.15TCr
Weighted average by Cap.	23.87x	7.78x	17.95x	1.98%